Good Morning All,
Thought the following information may be of some use.
THALIDOMIDE IN ONCOLOGY: THE PERIL AND THE PROMISE
Review the history and latest research of this promising antiangiogenic
agent.
Cancer Control; JMCC 6(5):483-495, 1999
http://www.medscape.com/17851.rhtml
Note - to read this, you must be a subscriber to MEDSCAPE. It is easy to
subscribe. See instructions at the website.
God Bless All,
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
